We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 99.07 | 19 | 09:47:56 |
From May 2022 to May 2024
By Joshua Kirby
Novartis AG said Thursday that Swiss competition-authority officers visited the company's headquarters as part of an investigation into a patent assertion.
The investigation is being carried out by the Swiss Competition Commission, or COMCO, in collaboration with the European Union's executive arm the European Commission, the pharmaceutical company said.
The investigation, which is looking into Novartis's assertion of a patent in the broader field of dermatology treatments, doesn't imply any wrongdoing or financial impact, the company said. COMCO representatives have visited the company's offices in Basel, Switzerland, Novartis said, adding that it is cooperating with the authorities and is confident of clarifying its position.
Write to Joshua Kirby at joshua.kirby@wsj.com; @joshualeokirby
(END) Dow Jones Newswires
September 15, 2022 02:01 ET (06:01 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
